BioStem made the announcement on November 20, 2024. The company indicated that the acquisition of revyve TM Antimicrobial Wound Gel reflects BioStem’s continued commitment to building a diverse ...
WINNIPEG, Manitoba, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V ... rights for Kane’s revyve TM Antimicrobial Wound Gel. BioStem made the announcement on November 20, 2024.
The company indicated that the acquisition of revyveTM Antimicrobial Wound Gel reflects BioStem's continued ... spectrum and around the world. Kane Biotech Inc. is a biotechnology company engaged ...
WINNIPEG, Manitoba, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE ... s revyveTM Antimicrobial Wound Gel. BioStem made the announcement on November 20, 2024. The company indicated ...